SistemTox™ : Predictive and Investigative Toxicology in vitro

SistemTOX™ builds on SistemRNA™ data to help companies detect compounds, which activate pathways potentially leading to toxicity, earlier in the lead selection process. This service is applicable to cell lines such as HepG2, as well as stem cells derived from hepatocytes and cardiomyocytes. SistemTOX™ not only gives a simple, rapid yes/no answer, but provides the context needed to gain a much deeper insight. This depth of knowledge allows drug developers to reduce risks within their pipeline and enhance their chances of success.